Katherine A. Collins, Ph.D. - Publications

Neurosciences Icahn School of Medicine at Mount Sinai, New York, NY, United States 
reconsolidation, reversal learning, inhibition of fear, fMRI, SCR

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Abdallah CG, Averill LA, Collins KA, Geha P, Schwartz J, Averill C, DeWilde KE, Wong E, Anticevic A, Tang CY, Iosifescu DV, Charney DS, Murrough JW. Ketamine Treatment and Global Brain Connectivity in Major Depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27604566 DOI: 10.1038/Npp.2016.186  1
2016 Murrough JW, Abdallah CG, Anticevic A, Collins KA, Geha P, Averill LA, Schwartz J, DeWilde KE, Averill C, Jia-Wei Yang G, Wong E, Tang CY, Krystal JH, Iosifescu DV, Charney DS. Reduced global functional connectivity of the medial prefrontal cortex in major depressive disorder. Human Brain Mapping. PMID 27144347 DOI: 10.1002/Hbm.23235  1
2015 Byers CE, Barylko B, Ross JA, Southworth DR, James NG, Taylor CA, Wang L, Collins KA, Estrada A, Waung M, Tassin TC, Huber KM, Jameson DM, Albanesi JP. Enhancement of dynamin polymerization and GTPase activity by Arc/Arg3.1. Biochimica Et Biophysica Acta. 1850: 1310-8. PMID 25783003 DOI: 10.1016/J.Bbagen.2015.03.002  1
2015 Murrough JW, Collins KA, Fields J, DeWilde KE, Phillips ML, Mathew SJ, Wong E, Tang CY, Charney DS, Iosifescu DV. Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder. Translational Psychiatry. 5: e509. PMID 25689570 DOI: 10.1038/Tp.2015.10  1
2015 Murrough JW, Soleimani L, DeWilde KE, Collins KA, Lapidus KA, Iacoviello BM, Lener M, Kautz M, Kim J, Stern JB, Price RB, Perez AM, Brallier JW, Rodriguez GJ, Goodman WK, et al. Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial Psychological Medicine. DOI: 10.1017/S0033291715001506  1
2014 Collins KA, Mendelsohn A, Cain CK, Schiller D. Taking action in the face of threat: neural synchronization predicts adaptive coping. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 14733-8. PMID 25355225 DOI: 10.1523/Jneurosci.2152-14.2014  1
2014 Iacoviello BM, Wu G, Alvarez E, Huryk K, Collins KA, Murrough JW, Iosifescu DV, Charney DS. Cognitive-emotional training as an intervention for major depressive disorder. Depression and Anxiety. 31: 699-706. PMID 24753225 DOI: 10.1002/Da.22266  1
2013 Jakkamsetti V, Tsai NP, Gross C, Molinaro G, Collins KA, Nicoletti F, Wang KH, Osten P, Bassell GJ, Gibson JR, Huber KM. Experience-induced Arc/Arg3.1 primes CA1 pyramidal neurons for metabotropic glutamate receptor-dependent long-term synaptic depression. Neuron. 80: 72-9. PMID 24094104 DOI: 10.1016/J.Neuron.2013.07.020  1
2013 Murrough JW, Wan LB, Iacoviello B, Collins KA, Solon C, Glicksberg B, Perez AM, Mathew SJ, Charney DS, Iosifescu DV, Burdick KE. Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response. Psychopharmacology. PMID 24022236 DOI: 10.1007/S00213-013-3255-X  1
2013 Collins KA, Schiller D. What can fear and reward learning teach us about depression? Current Topics in Behavioral Neurosciences. 14: 223-42. PMID 23299804 DOI: 10.1007/7854_2012_236  1
2013 Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, Collins KA, Mathew SJ, Charney DS, Iosifescu DV. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biological Psychiatry. 74: 250-6. PMID 22840761 DOI: 10.1016/J.Biopsych.2012.06.022  1
2012 Ronesi JA, Collins KA, Hays SA, Tsai NP, Guo W, Birnbaum SG, Hu JH, Worley PF, Gibson JR, Huber KM. Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome. Nature Neuroscience. 15: 431-40, S1. PMID 22267161 DOI: 10.1038/nn.3033  1
2011 Murrough JW, Gallo JM, Collins KA, Aan Het Rot M, Charney DS. Reply to: Dose- and exposure-response to ketamine in depression Biological Psychiatry. 70: e11-e12. DOI: 10.1016/J.Biopsych.2011.02.018  1
2010 Barylko B, Wang L, Binns DD, Ross JA, Tassin TC, Collins KA, Jameson DM, Albanesi JP. The proline/arginine-rich domain is a major determinant of dynamin self-activation. Biochemistry. 49: 10592-4. PMID 21082776 DOI: 10.1021/Bi101343P  1
2010 Murrough JW, Mao X, Collins KA, Kelly C, Andrade G, Nestadt P, Levine SM, Mathew SJ, Shungu DC. Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder. Nmr in Biomedicine. 23: 643-50. PMID 20661876 DOI: 10.1002/Nbm.1512  1
2010 aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, Mathew SJ. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biological Psychiatry. 67: 139-45. PMID 19897179 DOI: 10.1016/J.Biopsych.2009.08.038  1
2010 Mathew SJ, Murrough JW, aan het Rot M, Collins KA, Reich DL, Charney DS. Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 71-82. PMID 19288975 DOI: 10.1017/S1461145709000169  1
2008 Dumitriu D, Collins K, Alterman R, Mathew SJ. Neurostimulatory therapeutics in management of treatment-resistant depression with focus on deep brain stimulation Mount Sinai Journal of Medicine. 75: 263-275. PMID 18704979 DOI: 10.1002/Msj.20044  1
Show low-probability matches.